Copyright
©2012 Baishideng Publishing Group Co.
World J Hepatol. Dec 27, 2012; 4(12): 382-388
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.382
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.382
Table 4 Scoring for the grade and stage of non alcoholic steatohepatitis n (%)
| Scores | |||||
| 0 | 1 | 2 | 3 | P value | |
| Grade | |||||
| At surgery | 1 (3.8) | 12 (46.1) | 11 (42.3) | 2 (7.7) | 0.001 |
| Follow up biopsy | 22 (84.6) | 4 (15.4) | 0 (0) | 0 (0) | |
| Stage | |||||
| At surgery | 1 (3.8) | 17 (65.4) | 6 (23.1) | 2 (7.7) | 0.001 |
| Follow up biopsy | 9 (34.6) | 12 (46.1) | 4 (15.4) | 1 (3.8) | |
- Citation: Vargas V, Allende H, Lecube A, Salcedo MT, Baena-Fustegueras JA, Fort JM, Rivero J, Ferrer R, Catalán R, Pardina E, Ramón y Cajal S, Guardia J, Peinado-Onsurbe J. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients. World J Hepatol 2012; 4(12): 382-388
- URL: https://www.wjgnet.com/1948-5182/full/v4/i12/382.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i12.382